Carnitine Deficiency And Medical Use True carnitine deficiency is rare and often related to genetic conditions or secondary issues such as dialysis
This review summarizes CHE as a multi-organ syndrome, focusing on the gut-liver-muscle-brain axis, diagnosis, treatment, and future challenges and directions for clinical implementation
Cancer Summary Keywords transporters, SLC, mitochondria, -oxidation, carnitine, cancer, drugs Citation Console L, Scalise M, Mazza T, Pochini L, Galluccio M, Giangregorio N, Tonazzi A and Indiveri C (2020) Carnitine Traffic in Cells
This classification acknowledges BPC-157's status as a compound not approved for human therapeutic use by regulatory authorities
This product is not a drug, food, cosmetic, or dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease
Regulatory Support That Reduces Risk Our in-house regulatory team assists partners with product registration, dossier preparation, and compliance, ensuring faster time-to-market and smooth navigation of country-specific requirements - a key advantage in regions like LATAM and MENA markets, where processes are complex